Salinomycin decreases doxorubicin resistance in hepatocellular carcinoma cells by inhibiting the β-catenin/TCF complex association via FOXO3a activation-Reference-Cited by-同舟云学术

Salinomycin decreases doxorubicin resistance in hepatocellular carcinoma cells by inhibiting the β-catenin/TCF complex association via FOXO3a activation

Published:2015-03-14 Issue:12 Volume:6 Page:10350-10365
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Zhou Yue¹,Liang Chao¹,Xue Fei²,Chen Wei¹,Zhi Xiao¹,Feng Xinhua³,Bai Xueli¹,Liang Tingbo¹

Affiliation:

1. Department of Hepatobiliary and Pancreatic Surgery, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, PR China

2. Department of Hepatobiliary and Pancreatic Surgery, People's Hospital of Zhengzhou University, School of Medicine, Zhengzhou University, Zhengzhou, PR China

3. Life Sciences Institute and Innovation Center for Cell Signaling Network, Zhejiang University, Hangzhou, PR China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ESL attenuates BLM-induced IPF in mice: Dual mediation of the TLR4/NF-κB and TGF-β1/PI3K/Akt/FOXO3a pathways;Phytomedicine;2024-09

2. Exploring the relationship between anastasis and mitochondrial ROS-mediated ferroptosis in metastatic chemoresistant cancers: a call for investigation;Frontiers in Immunology;2024-07-02

3. Exploiting transcription factors to target EMT and cancer stem cells for tumor modulation and therapy;Seminars in Cancer Biology;2024-05

4. FOXO3a-interacting proteins’ involvement in cancer: a review;Molecular Biology Reports;2024-01-25

5. Doxorubicin and other anthracyclines in cancers: Activity, chemoresistance and its overcoming;Molecular Aspects of Medicine;2023-10